Westlake Village-based Turn Therapeutics, a medical device company focused on advanced wound and dermatologic care, announced a strategic investment from a large private equity firm, which also hints at the biotech going public in the near future. According to the Dec. 12 press release, the agreement provides Turn Therapeutics with a commitment of up to $75…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
